Juliette Pike
Analyst
Juliette Pike is an analyst at Back Bay Life Sciences Advisors on the Investment Banking Team.
Prior to joining Back Bay Juliette was a Summer Equity Research Associate at Stifel on their biotechnology/therapeutics coverage team. She carried our primary and secondary research on 25+ public small to large cap companies focusing on neurodegenerative and rare genetic diseases. She also conducted company and industry research on AI healthcare delivery in the U.S. on the Health Tech Investments Team in the Innovation Institute at the Hospital for Special Surgery (HSS) in New York City. At HSS, Juliette was originally apart of the Global Markets and Data Insights Team under the Global Partnerships Program and supported the HSS Orthopedic Knowledge Exchange.
Juliette graduated from Hobart and William Smith Colleges with a B.S. in Biology and minor in Economics. There, she completed her senior independent capstone regarding current research and treatment on Alzheimer's Disease (AD). More specially she developed a multi-step model of AD to reconsider the prevailing Amyloid Cascade Hypothesis. .